These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Secrecy and transparency of medicines licensing in the EU. Abraham J; Lewis G Lancet; 1998 Aug; 352(9126):480-2. PubMed ID: 9708771 [No Abstract] [Full Text] [Related]
3. Drug safety in the digital age. Hwang TJ; Bourgeois FT; Seeger JD N Engl J Med; 2014 Jun; 370(26):2460-2. PubMed ID: 24963564 [No Abstract] [Full Text] [Related]
4. Communicating with patients about their medications. Kessler DA N Engl J Med; 1991 Dec; 325(23):1650-2. PubMed ID: 1944456 [No Abstract] [Full Text] [Related]
5. Management of medicines information for patient safety. Pappa D; Telonis P; Stergioulas LK J Telemed Telecare; 2006; 12 Suppl 1():34-6. PubMed ID: 16884574 [TBL] [Abstract][Full Text] [Related]
6. Better communication urged for pharmaceutical manufacturers. Woods D Can Med Assoc J; 1984 Jun; 130(11):1488-9. PubMed ID: 6733620 [No Abstract] [Full Text] [Related]
7. Is drug advertising informing the consumer? Hanlon PM Behav Healthc Tomorrow; 2002 Feb; 11(1):SR35-7. PubMed ID: 11837141 [No Abstract] [Full Text] [Related]
8. Information from drug companies and opinion leaders. Liberati A; Magrini N BMJ; 2003 May; 326(7400):1156-7. PubMed ID: 12775588 [No Abstract] [Full Text] [Related]
9. Quality control of drug information transfer. Ruskin A Drug Inf J; 1975; 9(2-3):89-90. PubMed ID: 10236984 [No Abstract] [Full Text] [Related]
10. Drug information: how much is too much? Suggestions for improving the sources of drug information. Devetski RL Indiana Med; 1986 Apr; 79(4):368-9. PubMed ID: 3711651 [No Abstract] [Full Text] [Related]
11. Modifications in the Paul de Haen Drug Information System. Groth PE Am J Hosp Pharm; 1979 Jun; 36(6):745. PubMed ID: 463889 [No Abstract] [Full Text] [Related]
12. [Quality assurance for drug information]. Järhult B Lakartidningen; 1992 Dec; 89(51-52):4485. PubMed ID: 1335105 [No Abstract] [Full Text] [Related]
13. [Can we rely on drug information?]. Myhr K Tidsskr Nor Laegeforen; 2002 Nov; 122(27):2644-6. PubMed ID: 12523198 [No Abstract] [Full Text] [Related]
14. Role of drug bulletins. Font M Lancet; 2006 Nov; 368(9549):1766-7. PubMed ID: 17113416 [No Abstract] [Full Text] [Related]
15. Freedom for drug information. Lancet; 1993 Mar; 341(8845):598-9. PubMed ID: 8094833 [No Abstract] [Full Text] [Related]
16. [How to improve drug information!]. Järhult B Lakartidningen; 1998 Jul; 95(30-31):3278-9. PubMed ID: 9715057 [No Abstract] [Full Text] [Related]
17. [Offer for better drug information]. Højgaard L Ugeskr Laeger; 1994 Feb; 156(6):832-3. PubMed ID: 8016994 [No Abstract] [Full Text] [Related]
18. Drug information scientific versus commercial. Bajaj G; Aneja S Indian Pediatr; 1990 Nov; 27(11):1230-1. PubMed ID: 2081652 [No Abstract] [Full Text] [Related]
19. [Communication and transparency concerning risk-benefit analysis in public health: the example of medication]. Lehner JP; Meyer F; Juillet Y Therapie; 2001; 56(4):335-9. PubMed ID: 11677849 [TBL] [Abstract][Full Text] [Related]
20. The ISS National Inventory of Chemical Substances (INSC). Binetti R; Costamagna FM; Ceccarelli F; D'angiolini A; Fabri A; Riva G; Satalia S; Marcello I Ann Ist Super Sanita; 2008; 44(1):16-26. PubMed ID: 18469372 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]